|
⚲
|
| Keyboard |
| Ashton-Rickardt Philip
✚
|
|
|---|---|
| CIK # | 0001866197 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001866197] | |
| 4 | [0001866197] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sigilon Therapeutics Inc | |
| Ashton-Rickardt Philip |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Sigilon Therapeutics Inc SGTX
Stock Option (Right to Buy) · derivative
|
2023-08-11 | Disposed to issuer | 8,845 | $0.75 | 6,634 |
|
Sigilon Therapeutics Inc SGTX
Stock Option (Right to Buy) · derivative
|
2023-02-28 | Grant | 115,000 | $0.00 | |
|
Sigilon Therapeutics Inc SGTX
Stock Option (Right to Buy) · derivative
|
2022-02-18 | Grant | 90,000 | $1.48 | 133,200 |
|
Sigilon Therapeutics Inc SGTX
Stock Option (Right to Buy) · derivative
|
2022-01-03 | Grant | 90,000 | $3.03 | 272,700 |
|
Sigilon Therapeutics Inc SGTX
Stock Option (Right to Buy) · derivative
|
2021-07-01 | Grant | 90,000 | $0.00 |